Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
2.
Q J Nucl Med Mol Imaging ; 58(3): 237-57, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25265246

ABSTRACT

Increasing interest and research efforts have been made in search of specific radiolabelled probes for imaging different immune cells (including T-lymphocytes) in inflammation and infection. This has led to early detection of lymphocyte infiltration, and the deepening of our understanding of pathogenesis of immune mediated diseases. In-vivo imaging of T-lymphocytes with radiolabelled specific probes may provide an important piece of information about inflammatory lesions, which could be very important to understand the molecular mechanism of action of any drug and/or their effect on the microenvironment of the immune system of the body. The present review focuses on radiolabelled T-lymphocytes and different monoclonal antibodies, peptides, cytokines, chemokine used for scintigraphic imaging of T-lymphocytes and their subsets.


Subject(s)
Cell Tracking/methods , Inflammation/diagnostic imaging , Inflammation/immunology , Radiopharmaceuticals , T-Lymphocytes/diagnostic imaging , T-Lymphocytes/immunology , Tomography, Emission-Computed/methods , Animals , Humans , Inflammation/pathology , Radiopharmaceuticals/immunology
3.
Q J Nucl Med Mol Imaging ; 54(6): 654-76, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21221072

ABSTRACT

Acute and chronic forms of inflammation may occur years before the onset of specific symptoms, on which the clinical diagnosis can be settled, and may last for years after the clinical diagnosis and the onset of treatment. Therefore, to develop a sensitive and specific diagnostic tool several novel molecules/ receptors identified and new antibodies have been radiolabelled with different radionuclides, as per their need for diagnosis or therapy. Cluster of differentiation (CD) molecules are markers on the cell surface used to identify the cell type, stage of differentiation and activity of a cell. These CD markers are recognized by specific monoclonal antibodies (mAbs). These radiolabelled mAbs bind to their targets with high affinity and specificity and consequently have an excellent diagnostic and/ or therapeutic potential. In the last two decades, the radiolabelled mAbs have demonstrated its significant impact on diagnosis and radioimmunotherapy. In this review article, we will discuss different possible targets for T and B cells and their radiolabelled mAbs for molecular imaging and radioimmunotherapy.


Subject(s)
Antibodies, Monoclonal/therapeutic use , B-Lymphocytes/diagnostic imaging , Inflammation/diagnostic imaging , Inflammation/radiotherapy , T-Lymphocytes/diagnostic imaging , Animals , Antigens, Differentiation/immunology , B-Lymphocytes/immunology , Drug Delivery Systems/trends , Humans , Inflammation/immunology , Inflammation/pathology , Isotope Labeling/trends , Molecular Imaging/trends , Radioisotopes/immunology , Radioisotopes/therapeutic use , Radionuclide Imaging , Radiopharmaceuticals/immunology , Radiopharmaceuticals/therapeutic use , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...